Science11 sources

Experimental drug shows promise in slowing Alzheimer's progression

  • A drug related to Viagra, AR1001 or mirodenafil, showed a 31% reduction in cognitive decline in early Alzheimer's patients.
  • Early results from a phase III clinical trial suggest the drug holds promise for Alzheimer's treatment.
  • Boosting a protein called SORLA significantly reduced toxic tau tangles in mice, offering hope for new Alzheimer's treatments.
  • The drug showed mixed results in people with early Alzheimer's disease in the phase III POLARIS-AD trial.
  • The findings are described as 'very promising' by experts and could lead to the first pill to slow Alzheimer's progression.

Timeline

  1. Viagra-like drug shows promise against Alzheimer’s, but there’s a catch

    An experimental pill related to Viagra, called AR1001 or mirodenafil, showed potential in slowing early Alzheimer’s disease.

  2. A little-known protein could be a powerful weapon against Alzheimer’s

    Scientists discovered that boosting the protein SORLA could significantly reduce toxic tau tangles in mice, offering new treatment hope.

  3. Erectile dysfunction drug could hold promise for Alzheimer’s disease

    Early results from a phase III clinical trial suggest the drug holds promise for treating Alzheimer’s disease.

  4. Latest

    Alzheimer’s brain decline slashed in half by ‘thrilling’ new twice-a-year drug:…

    A major medical breakthrough may be on the horizon with a new drug that significantly reduces Alzheimer’s brain decline.

Experimental drug shows promise in slowing Alzheimer's progression | Split Angle